OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.65+0.24 (+0.76%)
Close on Nov 18, 2026Market cap $826.40MP/E –Yield –
OrthoPediatrics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
OrthoPediatrics's price to sales ratio was 3.2× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 1.6× to 12.8×, with a median of 4.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | +1.3 |
| 2025 | Dec 31, 2025 | 1.8× | −1.0 |
| 2024 | Dec 31, 2024 | 2.8× | −2.5 |
| 2023 | Dec 29, 2023 | 5.3× | −2.5 |
| 2022 | Dec 30, 2022 | 7.8× | −4.9 |
| 2021 | Dec 31, 2021 | 12.8× | +1.4 |
| 2020 | Dec 31, 2020 | 11.3× | +1.0 |
| 2019 | Dec 31, 2019 | 10.3× | +2.1 |
| 2018 | Dec 31, 2018 | 8.2× | +7.1 |
| 2017 | Dec 29, 2017 | 1.1× | – |
See a number that looks wrong?